Are social phobia and paranoia related, and which comes first? by Rietdijk, J. et al.
  
PLEASE SCROLL DOWN FOR ARTICLE
This article was downloaded by: [Vrije Universiteit, Library]
On: 14 December 2010
Access details: Access Details: [subscription number 910948958]
Publisher Routledge
Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: Mortimer House, 37-
41 Mortimer Street, London W1T 3JH, UK
Psychosis
Publication details, including instructions for authors and subscription information:
http://www.informaworld.com/smpp/title~content=t777186832
Are social phobia and paranoia related, and which comes first?
J. Rietdijka; J. van Osb; R. de Graafc; Ph. Delespaulbd; M. van der Gaagae
a VU University Amsterdam, The Netherlands b Maastricht University, Maastricht, The Netherlands c
Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands d Mondriaan,
Maastricht, The Netherlands e Parnassia Psychiatric Institute, The Hague, The Netherlands
To cite this Article Rietdijk, J. , van Os, J. , Graaf, R. de , Delespaul, Ph. and Gaag, M. van der(2009) 'Are social phobia and
paranoia related, and which comes first?', Psychosis, 1: 1, 29 — 38
To link to this Article: DOI: 10.1080/17522430802654105
URL: http://dx.doi.org/10.1080/17522430802654105
Full terms and conditions of use: http://www.informaworld.com/terms-and-conditions-of-access.pdf
This article may be used for research, teaching and private study purposes. Any substantial or
systematic reproduction, re-distribution, re-selling, loan or sub-licensing, systematic supply or
distribution in any form to anyone is expressly forbidden.
The publisher does not give any warranty express or implied or make any representation that the contents
will be complete or accurate or up to date. The accuracy of any instructions, formulae and drug doses
should be independently verified with primary sources. The publisher shall not be liable for any loss,
actions, claims, proceedings, demand or costs or damages whatsoever or howsoever caused arising directly
or indirectly in connection with or arising out of the use of this material.
Psychosis
Vol. 1, No. 1, February 2009, 29–38
ISSN 1752-2439 print/ISSN 1752-2447 online
© 2009 Taylor & Francis
DOI: 10.1080/17522430802654105
http://www.informaworld.com
Are social phobia and paranoia related, and which comes first?
J. Rietdijk,*a J. van Os,b R. de Graaf,c Ph. Delespaulb,d and M. van der Gaaga,e
aVU University Amsterdam, The Netherlands; bMaastricht University, Maastricht, The 
Netherlands; cNetherlands Institute of Mental Health and Addiction, Utrecht, The 
Netherlands; dMondriaan, Maastricht, The Netherlands; eParnassia Psychiatric Institute, 
The Hague, The Netherlands
Taylor and FrancisRPSY_A_365580.sgm(Received 15 October 2008; final version received 29 November 2008)
10.1080/17522430802654105Psychosis752-2439 (print)/1752-2447 (online)Research Article2 08Ta lo  & Francis0 0002008Mi s JudithR etdijkj.r etdijk@psyq.nl
Social phobia (SPh) and paranoid symptoms (PS) are associated. They may
overlap because they share psychological and behavioural mechanisms such as
selective attention for social threats and avoidance behaviour. Possibly, one leads
to the other. The aim of this study is to explore the association between SPh and
PS in a prospective general population sample.
Adults (7076) from the NEMESIS general population were assessed for SPh
and PS using the Composite International Diagnostic Interview (CIDI) at baseline,
and one and three years later. Odds ratios, dose–response relationships and
confidence intervals were calculated.
Lifetime SPh and PS were associated (OR=3.08; 95% CI=2.49–3.82; p<.001),
with a dose response. SPh emerging after PS was significant (OR=4.07; 95%
CI=2.50–6.63; p<.001), also with a dose response, i.e. more PS symptoms yield
more SPh symptoms. PS emerging after SPh was not significant.
This study confirmed the association of SPh and PS in a general population.
Possibly this is caused by shared underlying psychological and behavioural
processes. There was some indication that paranoid ideation precedes the
development of SPh, but this must be considered with caution. Clinical implications
are discussed.
Keywords: paranoid symptoms; social phobia; comorbidity; general population
survey
Introduction
In DSM IV, social phobia (SPh) and paranoid disorders are separate disease entities.
While they are regarded as non-overlapping disorders, they share psychological and
behavioural mechanisms. Gilbert and colleagues found an association between
paranoid ideation and social anxiety in a clinical population and suggested an overlap
in psychological etiology (Gilbert, Boxal, Cheung, & Irons, 2005). Both groups of
patients think that they are the object of other people’s interest and they are judged by
others. They scan their environment for socially threatening information and they
both have a strong self-referencing bias. Both social phobic and paranoid people
easily conclude that people are talking about them (Beck, Emery, & Greenberg, 1985;
Fenigstein & Vanable, 1992). They might share psychological mechanisms, but be
acting on different motives. Whereas the social phobic patient is afraid of rejection,
*Corresponding author. Email: j.rietdijk@psyq.nl
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the paranoid person is afraid of persecution. Figure 1 shows these overlapping
mechanisms in SPh and PS. Other studies even suggest a relationship between social
phobia and psychosis in general. Voges and Addington (2005) found that 31% of the
first-episode psychosis patients met the criteria for SPh. This was confirmed by
Birchwood and colleagues (2006).
Figure 1. The overlap and differences of psychological processes in social phobia and paranoid ideation.Several explanations for the high rate of SPh in people with a psychotic disorder,
and the high rate of psychosis in people with SPh, have been proposed. The first
explanation is that symptom clusters overlap (Birchwood et al., 2006; Gilbert et al.,
2005). The second is that SPh is a psychological reaction to psychosis. Birchwood and
colleagues found that SPh emerges after the onset of psychosis. Possibly, they have
more stigmatizing thoughts about their illness (Birchwood et al., 2006). A third
explanation is that SPh is a co-morbid or a prodromal symptom of schizophrenia
(Cassano, Pini, Settoni, & Dell’Oso, 1998; Pallanti, Quercioli, & Hollander, 2004).
According to Blanchard and colleagues (1998), SPh is a stable trait that remains
unrecognized because its expression is overshadowed by the negative symptoms.
There is also some evidence that social or situation anxiety is a predictor of future
psychosis in a genetic at-risk group (Cunningham Owens, Miller, Lawrie, &
Johnstone, 2005; Tien & Eaton, 1992).
Population studies have found that psychotic-like experiences – such as suspicious-
ness, hearing thoughts aloud or low-frequency hallucinatory whispering sounds – are
quite prevalent (Van Os, Krabbendam, Myin-Germeys, & Delespaul, 2005). This
presents the opportunity to examine the association of SPh and paranoid ideation in a
Figure 1. The overlap and differences of psychological processes in social phobia and paranoid
ideation.
D
o
w
n
lo
ad
ed
 B
y:
 [
Vr
ij
e 
Un
iv
er
si
te
it
, 
Li
br
ar
y]
 A
t:
 1
2:
44
 1
4 
De
ce
mb
er
 2
01
0
Psychosis  31
general population cohort. A prospective study cohort could reveal some temporal
aspects of the association. The aim of this study is to explore the association between
SPh and sub-clinical paranoid symptoms (PS) in a prospective general population
sample. As far as we know, this is the first study of this kind. Most of the studies cited
above, investigated psychotic patients (Blanchard et al., 1998; Cassano et al., 1998;
Pallanti et al., 2004; Voges & Addington, 2005; Birchwood et al., 2006). The sample
in the study by Cunningham Owens and colleagues was at genetic risk for schizophrenia
(Cunningham Owens et al., 2005). This subgroup forms only 15% of the group which
is at risk for psychosis (Yung et al., 2003) and a population cohort is therefore more
representative. 
Previous research in psychotic patients points to an association between SPh and
PS. Can this be replicated for sub-clinical symptoms in a general population? Three
hypotheses were tested: 
(1) SPh and sub-clinical PS are associated;
(2) the onset of SPh emerges after the presence of sub-clinical PS; and
(3) the onset of sub-clinical PS emerges after the presence of SPh.
Materials and methods
Sample
This study used the data of the Netherlands Mental Health Survey and Incidence Study
(NEMESIS). NEMESIS is a prospective study of the prevalence, incidence and course
of mental disorders in a representative Dutch population cohort of 7076 adults between
18 and 64 years of age. Subjects were selected by a multistage, stratified, random
sampling procedure in 90 Dutch municipalities. Stratification criteria included urba-
nicity and sufficient spreading over the 12 Dutch provinces. Within the municipalities,
a proportional number of private households were approached, and the person with
the most recent birthday was selected. Persons residing in institutions, including
psychiatric hospitals, were excluded from the sample.
At baseline, 7076 individuals (response rate=69.7%) provided informed consent
and completed the first interview. The research sample was representative of the
Dutch population. At least one of the follow-up interviews after one or three years was
completed by 5619 respondents.
For a complete description of the study design, sample procedures, quality control
procedures and analyses, see Bijl, Zessen, Ravelli, Rijk, and Langendoen (1998).
CIDI interview
Respondents were interviewed by trained lay interviewers using the Composite Inter-
national Diagnostic Interview (CIDI, version 1.1. computerized version; World Health
Organization, 1990). The CIDI generates Axis I disorders according to DSM-III-R.
The World Health Organization developed the CIDI on the basis of the Diagnostic
Interview Schedule (DIS) and the Present State Examination (PSE). The CIDI is being
used in epidemiological research projects all over the world. It has high inter-rater
reliability, high test–retest reliability and high validity for all diagnoses, except for
psychotic disorders.
When a person was suspected of psychotic symptoms, he or she was re-interviewed
by a clinical psychiatrist using the Structured Clinical Interview for DSM III-R (SCID).
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This interview established the presence of psychotic symptoms and the diagnoses of
schizophrenia and other non-affective psychotic disorders in NEMESIS.
The CIDI psychosis section has 17 items. The first four assess paranoid ideation:
(1) “Have you ever been convinced that people were spying on you?”; (2) “Has there
ever been a period in which you were convinced that you were persecuted by
people?”; (3) “Have you ever been convinced that you were secretly tested on or that
experiments were carried out on you?”; and (4) “Have you ever been convinced that
someone was conspiring against you, wanted to cause you harm or poisoning you?”
For each item 6 options are possible: 1 is no symptom; 2, psychotic symptom present
but not clinically relevant; 3, psychotic symptom is the result of drug use; 4, symptom
is the result of disease; 5, true psychotic symptom; and 6, interviewer is in doubt
because there appears to be some logical explanation for what emerges as a psychotic
symptom. Presence of paranoid symptoms was broadly defined as any rating between
2 and 6 in one of the four paranoia CIDI items. The ‘present’ ratings on the CIDI
psychosis items are strongly correlated (Van Os, Hanssen, Bijl, & Ravelli, 2000).
The CIDI anxiety section contains ten questions related to SPh. Because those
assessments are considered valid no cross-check was done. Subjects who met the
DSM criteria for SPh were recorded as such in the database.
Statistical analyses
Odds ratios (OR) and 95% confidence intervals (CI) were calculated for each hypoth-
esis. The relation between PS and SPh was tested using baseline (T0) data. The
second hypothesis was tested by excluding subjects with lifetime SPh at baseline and
calculating the OR among those with lifetime PS at baseline for developing SPh
between T0 and T2. The third hypothesis was tested by excluding subjects with life-
time PS at baseline and calculating the OR among those with lifetime SPh at baseline
for developing PS between T0 and T2.
Krabbendam and Van Os (2005) found that neuroticism was associated with
psychosis as well as all anxiety disorders. Since this study aims to explore a specific
association between paranoia and SPh, we controlled the ORs for the shared variance
with neuroticism. Neuroticism was rated using the Groningen Scale as in other
NEMESIS publications.
We used STATA statistical package, version 10 (StataCorp, 2008) to calculate the
ORs, the 95% confidence intervals and the p-values.
Results
Sample
Of the original 7076 subjects at T0, 5619 persons completed the CIDI on at least one
additional measurement. There were 2614 men and 3005 women. The mean age was
41 years (SD=12 years). At baseline, a total of 575 individuals (8%) reported lifetime
SPh and 705 (10%) individuals reported one or more lifetime sub-clinical PS.
Hypothesis 1: Lifetime SPh and lifetime PS are associated
The odds ratio (OR) for the association between SPh and PS at baseline is shown in
Table 1. At baseline, 705 subjects reported lifetime sub-clinical PS. Of this subsample,
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132 (19%) subjects also reported lifetime SPh at baseline. Of the 575 subjects who
reported lifetime SPh at baseline, 132 (23%) persons also reported lifetime sub-clinical
PS at baseline (OR=3.09; 95% CI=2.94–3. 82; p<.001). The OR was 1.64, when
controlling for neuroticism, and remained significant (p<.001). A clear dose–response
relationship was found for number of PS: the OR increased from 2.30 (one symptom)
to 11.41 (four symptoms). When controlling for neuroticism, the dose–response
remained, but was not significant.
Hypothesis 2: The onset of SPh emerges after the presence of sub-clinical PS
To explore the relationship between sub-clinical PS at baseline and subsequently
developing SPh, we excluded the data of subjects who had lifetime SPh at baseline.
Eighty-four participants were unable to complete at least one of the follow-up
interviews and were excluded from the analysis. Among the remaining 489 subjects
who did have lifetime sub-clinical PS but no lifetime SPh at baseline, 23 subjects
developed SPh (4.7%). This was significant (OR=4.07; 95% CI=2.50–6.63; p<.001).
The OR remained significant after controlling for neuroticism (OR= 2.62; 95%
CI=1.57–4.36; p<.001). Dose–response analysis was conducted to measure whether
more sub-clinical PS resulted in higher probabilities of SPh. ORs increased from 3.22
(one paranoid symptom) to 7.62 (three symptoms) (Table 2). The dose–response
relationship is weaker after controlling for neuroticism and is no longer significant in
one of three steps.
Hypothesis 3: The onset of sub-clinical PS emerges after the presence of SPh
Thirty-eight subjects of those who reported SPh at baseline were lost to follow-up
and were excluded from the analysis. Among the remaining 405 subjects who
reported lifetime SPh at baseline, 8 (2.0%) developed sub-clinical PS after one to
Table 1. The association between lifetime SPh and lifetime PS.
Not adjusted for neuroticism Adjusted for neuroticism
SPh at T0 OR P 95% CI OR P 95% CI N
Any sub-clinical PS at T0 3.08 <.001 2.49–3.82 1.64 <.001 1.29–2.09 132
1 Sub-clinical PS 2.30 <.001 1.78–2.98 1.40 .020 1.05–1.88 79
2 Sub-clinical PS 3.89 <.001 2.66–5.69 2.17 .001 1.40–3.35 37
3 Sub-clinical PS 3.72 <.001 1.89–7.28 1.58 .249 .73–3.44 11
4 Sub-clinical PS 11.41 <.001 3.29–39.55 1.83 .402 .44–7.57 5
Table 2. Transition to SPh from having PS at baseline.
Not adjusted for neuroticism Adjusted for neuroticism
SPh at T1–2 OR P 95% CI OR P 95% CI N
Any sub-clinical PS at T0 4.07 <.001 2.50–6.63 2.62 <.001 1.57–4.36 23
1 Sub-clinical PS 3.22 <.001 1.83–5.7 2.09 .015 1.15–3.80 15
2 Sub-clinical PS 4.01 .003 1.58–10.18 3.02 .024 1.16–7.85 5
3 Sub-clinical PS 7.62 <.001 2.25–25.80 3.67 .052 .99–13.60 3
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three years. The OR was non-significant (OR=2.00; 95%CI=.90–4.44; p=0.088;
see Table 3).
Discussion
Many patients show co-morbid SPh and PS in clinical practice. The aim of this
study was to explore the cross-sectional and temporal relationships between SPh and
sub-clinical PS. We used the data of the Dutch general population study NEMESIS:
a representative cohort of adults between 18 and 64 years of age. The analyses
demonstrated a significant association between lifetime SPh and lifetime sub-clinical
PS at baseline. This result confirms previous publications (Gilbert et al., 2005). Also
the suggestion that SPh and PS share psychological processes is supported by the
finding in a general population with relatively little psychopathology. The dose–
response relationship provides additional support for the hypothesis that there is an
association between paranoid ideation and social phobia.
Sub-clinical PS at baseline was associated with the onset of social phobia one to
three years later. These results are in line with the findings of Birchwood and
colleagues (2006) who found that social anxiety can be a result of a psychotic episode.
A possible rationale is that patients try to hide their discomfort, confusion or ‘madness’
by withdrawing from social contact and behaving like a socially phobic subject. People
monitor whether others are looking at them and become over-aware of their own
behaviour. The dose–response relationship further supports the hypothesis that para-
noid thoughts might lead to social phobia. Moreover, the inverse relation where social
phobia leads to paranoid ideation was not significant.
This study is not addressing the association of paranoia with general pathology,
but with specific aspects of social anxiety. We have tried to rule out the shared factors
of psychopathology by controlling for neuroticism. Neuroticism is a higher-order
construct that encompasses a broad range of emotional distress. It covers anxiety,
depression and irritability that is present in 60–80% of prodromal patients before the
onset of positive symptoms (Birchwood et al., 1992; Yung & McGorry, 1996). It
shares variance with many disorders, and also with SPh and paranoid ideation. As
expected, all the ORs decreased after controlling for neuroticism.
The hypothesis that SPh and PS are related is not new. Previous studies have
demonstrated that both SPh and PS share psychological mechanisms (Beck et al.,
1985; Fenigstein & Vanable, 1992; see Figure 1). Paranoid and socially phobic people
both share the belief that they are subjects of other people’s attention. They both share
a heightened self-consciousness, which means that they are overly aware of oneself
and worry about how others will perceive their behaviour. But they act on different
Table 3. Transition to PS from having SPh at baseline.
Not adjusted for neuroticism Adjusted for neuroticism
Incidence of sub-clinical 
PS at T1–2 OR P 95% CI OR P 95% CI N
SPh diagnose at T0 2.00 0.088 0.90–4.44 .89 .792 .40–2.00 8
0–5 SPh symptoms .57 .239 .22–1.45 .57 .241 .22–1.46 15
6–10 SPh symptoms .67 .701 .09–4.95 .633 .654 .09–4.65 1
11–15 SPh symptoms 7.62 .001 2.25–25.80 3.67 .052 .99–13.60 3
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motives. Socially anxious people are afraid that others will judge them as incompe-
tent, whereas paranoid people are afraid that others will persecute them. Fennigstein
and Vanable noted that this self-consciousness in PS leads to the perception of others’
behaviour as being intentionally focused against them. This is conceptualised as the
“self-as-target-bias” (Fenigstein & Vanable, 1992). Greenwald (1980) considered
self-consciousness as the defining characteristic of paranoia. In his understanding of
this notion, Laing (1969) argued that the self-conscious awareness of being an object
of others’ awareness leads to a heightened sense of being seen. Observation by others
becomes a prominent concern and is assumed more often than is actually the case.
Socially anxious people are also self-consciousness (Beck et al., 1985). They think
they are judged by others, just as paranoid persons do. Both groups scan the environ-
ment for socially threatening information and over-estimate the impact of their own
behaviour. Both have a self-reference bias and a confirmation bias, which means that
they perceive trivial stimuli to be important and meaningful to the self. And once a
threatening or anxious explanation occurs to them they will search for confirmation
and discard disconfirmatory evidence (Beck et al., 1985; Fenigstein & Vanable,
1992).
Individual psychopathology can overlap as well (Gilbert et al., 2005). People with
SPh sometimes report psychotic-like experiences. The excessive self-consciousness
makes them experience their voice as coming from an external source or their self as
being outside their body. This might explain why SPh with heightened self-
consciousness could lead to paranoia. However, in this study the hypothesis that
social phobia is a precursor of paranoid ideation was not confirmed (p=0.088) and no
dose–response relationship was found. What might explain this negative finding?
According to Freeman and colleagues an additional condition – also having percep-
tual aberrations – is necessary for social anxiety to evolve into delusions. In those
circumstances the thought that “something seems not to be right” is easily triggered
(Freeman et al., 2008).
Study limitations
Firstly, the numbers in the analysis of hypotheses two and three were small.
Although the original sample was large (N=7076), the analyses of the time sequenc-
ing of SPh and PS required subjects with conditional incidence. One hundred and
thirty-two subjects reported both lifetime SPh and sub-clinical PS at baseline and are
excluded for this analysis. The subjects with either SPh or PS at baseline can
develop the other condition at one of the follow-up moments. One condition clearly
preceded the other in only 31 subjects. Of these, 23 developed SPh after sub-clinical
PS and 8 developed sub-clinical PS after SPh. Sub-clinical PS seems to precede SPh
more often and this was significant. But because of the small numbers the conclu-
sions should be interpreted cautiously. It is not known whether the 132 lifetime
association subjects show the same pattern of development as these 31 subjects. It is
also unclear whether the exclusion of large numbers of subjects for the analyses of
time sequencing patterns altered the representativeness of the sample. When we
compared these subsamples on sex and age we found significant differences in
gender, but not in age. Having both lifetime SPh and lifetime SP at baseline was
significantly more present in woman (p=.032). To overcome these shortcomings,
additional prospective research of specific populations of social phobic or paranoid
patients is required.
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Second, the results do not tell us whether common psychological processes are
indeed involved in PS and SPh and their aetiology. The study focused on psychopa-
thology in both conditions, although the descriptions of the symptoms reveal some
psychological processes. While there is a clinical overlap and similarity in psycholog-
ical mechanisms in SPh and PS – it is still speculation whether they explain the
results in this study. More comprehensive psychological testing is necessary to
further examine this hypothesis. The same is true for social avoidance behaviour.
Both groups avoid all kinds of social situations but with different motives Subjects
with paranoid ideation fear persecution, while subjects with SPh fear rejection and
humiliation.
Third, the statistics were not adjusted for Type I error due to multiple comparison.
Findings at the <.05 significance level should therefore be interpreted with caution.
Fourth, sub-clinical PS was defined by the first four items of the psychosis section
of the CIDI (version 1.1). Although confirmed by a clinical psychiatrist, the scores
yield no information on the frequency or severity of the paranoid thoughts. More
nuances would have contributed to a better understanding of the quality or severity of
the paranoid thoughts.
Finally, psychotic symptoms – e.g. paranoia – are difficult to assess reliably in a
structured interview (the CIDI) conducted by trained lay interviewers. Since the
subjects were only re-interviewed when they were suspected of having psychotic
symptoms, we expect some false negative subjects in the NEMESIS database. Espe-
cially paranoid patients may withhold information in interviews with unacquainted
interviewers. It is likely that some of the paranoid subjects were not positive on the
CIDI and that they were not re-interviewed with the SCID. These subjects are not in
the analysis and therefore the ORs might be under-estimations.
Conclusion
This study found a significant relationship between SPh and sub-clinical PS in the
general population, with a dose response. Although the items described psychological
processes only indirectly, we cautiously suggest that the association may be due to an
overlap in psychological mechanisms in both conditions. Furthermore, there is
evidence that subjects with sub-clinical paranoid thoughts at baseline have a greater
risk of developing social anxiety over the next three years. There was no significant
evidence for the hypotheses that SPh precedes sub-clinical PS frequently.
The finding that in some individuals paranoid ideation results in social phobia has
clinical consequences. People might try to hide their suspiciousness from others and
develop a heightened awareness of their own behaviour and start scanning others to
see whether they have noticed their suspiciousness. This is consistent with, and may
partially account for, the “safety behaviours” that have been found to occur
frequently in people experiencing paranoid delusions (Morrison, 1998). These behav-
iours, first identified indeed in anxiety disorders such as social phobia, are adopted to
prevent a feared outcome but are problematic in that they can prevent disconfirma-
tion of beliefs about the feared outcome. Addressing these safety behaviours has
become an integral component of psychological formulations of paranoia (Bentall,
2003) and of cognitive therapy for paranoid delusions (Morrison, 2004). Clinicians
could benefit their patients by paying attention to both paranoid thoughts and socially
phobic behaviour. Indeed, focusing on social phobia might help alleviate some of the
secondary handicap caused by psychosis.
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